UBS Upgrades Solventum to Buy, Announces $95 Price Target

Benzinga Newsdesk www.benzinga.com Positive 80.2%

Neg 0% Neu 0% Pos 80.2%

UBS analyst Kevin Caliendo upgrades Solventum (NYSE:SOLV) from Neutral to Buy and announces $95 price target.

Comments

No comments yet. Be the first!